Abstract Background: The steep, time-dependent loss of benefit from reperfusion in clinical trials is consistent with loss of penumbra over the early hours of ischemia, as observed in animal models. Human imaging studies, however, show persistent penumbra for up to 48 h. We investigated core and penumbra volumes and collateral status in relation to time after stroke onset within the first 6 h.
Introduction
The concept of the ischemic penumbra segregates ischemic brain tissue according to flow thresholds, penumbra being the tissue below the threshold for electrical failure, but above the threshold for energy failure and loss of neuronal integrity, which define ischemic core. 1, 2 Conventionally, core is believed to grow over time at the expense of penumbra and is understood to be a consequence of the dynamic interaction of multiple factors including peri-infarct spreading depressions and adverse neurochemical events. 3 In animal models, transient middle cerebral artery (MCA) occlusion for 2-3 h results in moderate to large infarct sizes reaching that of permanent MCA occlusion, 4 ,5 while on PET 6 and multi-parametric imaging of protein and ATP synthesis, 7 penumbra was almost absent 6-8 h after permanent MCA occlusion.
Consistent with animal data on penumbra decline, the probability of favorable clinical outcome declines rapidly with increasing onset-to-treatment or onset-toreperfusion time for both IV Thrombolysis 8 and endovascular reperfusion 9 within the first 6-8 h after symptom onset. Although unproven, the concept of ''collateral failure'' and consequent penumbral loss as a function of duration of ischemia has been suggested as a possible explanatory factor for this time dependence. 10 Clinical imaging observations are, however, not uniformly consistent with this explanation. Several human studies show persistence of imaging features accepted as consistent with penumbra for much longer across modalities including PET, 11 MRI perfusion-diffusion mismatch 12 and for time periods of up to 48 h. Using Xenon Computed Tomography (CT) within 6 h of MCA occlusion, penumbra represented a constant proportion of MCA territory (32 AE 7%; range, 16.2% to 46.9%) while the proportion of core showed wide interindividual variation (37.6% AE 18.7%; range, 7.6% to 70.5%). 13 In proximal arterial occlusion, good collaterals were associated with both favorable tissue and clinical outcomes, while time from onset was unrelated to either collateral grade or mismatch proportion.
14 In patients treated with endovascular therapy, the interaction of good collaterals and reperfusion, but not time from symptom onset to reperfusion, influenced penumbral tissue loss. 15 We investigated the relationship of penumbra volume, collateral status and their interaction over time within 6 h of stroke onset.
Methods
Subjects were recruited at a single center for one of three multimodal imaging studies undertaken between 2008 and 2013. 16, 17 Two were observational studies, and one was a clinical trial comparing two thrombolytic agents. In the two observational studies (one investigating feasibility of complex imaging, one investigating pathophysiology of acute hyperglycaemia), all ischemic stroke patients aged above 18 years and presenting up to 6 h after symptom onset were eligible. In the clinical trial, patients eligible for thrombolysis within 4.5 h were randomized to receive either alteplase or tenecteplase. Patients were excluded if they had contraindications to contrast administration (history of allergy or estimated Glomerular Filtration Rate < 30 ml/min). In all studies, acute ischemic stroke patients underwent non-contrast CT (NCCT), CT angiography (CTA) and CT perfusion (CTP) imaging at baseline (<6 h after onset) with follow-up brain imaging with CT at approximately 24 h after recruitment, and repeat CTA if occlusion was present on baseline imaging. Clinical outcome was evaluated at 30 days or three months.
For this analysis, we selected subjects with a perfusion lesion and anterior territory arterial occlusion (ICA, M1, M2, or M3).
Imaging acquisition
All scans were performed on a Philips Brilliance 64 multidetector scanner. Whole brain NCCT was acquired first, (5 mm slice thickness FOV 218 Â 218 mm, 120 kv, 171 mA, or 0Á9 mm slice thickness, FOV 250 Â 250 mm, 120 kV, 404 mA) followed by CTP with 40 mm slab coverage from the basal ganglia (8 Â 5 mm slices, FOV 25 cm, 80 kVp, 476 mA, 2-s cycle time, 30 cycles) using a 50 ml contrast bolus administered at 5 ml per second (350 Xenetix) via a large-gauge cannula. A CTA covering aortic arch to the top of the lateral ventricles (0Á67 mm slice thickness, 120 kV, 475 mA) was acquired during the first arterial past of contrast (Xenetix 350, 60 ml, followed by 30 ml of saline bolus, both given at 5 ml per second).
Imaging processing and analysis
Imaging studies were anonymized and analyzed independently by two research fellows (BC, XH). CT perfusion was processed offline using MiStar (Apollo Medical Imaging Technology, Melbourne, Australia). Deconvolution of tissue enhancement curves and arterial input function selected from the anterior cerebral artery was performed using modified singular value decomposition (SVD) with compensation for the effects of arterial delay and dispersion. Delay time (DT) was determined by a delay corrected SVD deconvolution by applying a series of DT values, with actual delay time being minimum DT value, which produces T max ¼ 0. 18 Cerebral blood flow (CBF) and cerebral blood volume (CBV) were calculated from the peak height and area under tissue enhancement curves respectively, and mean transit time (MTT) ¼ CBV/CBF.
Penumbra definitions
Ischemic core was defined as tissue with reduced CBF (relative CBF < 40% of contralesional hemisphere) and prolonged delay time (relative DT > 2 sec); penumbra volume was defined as tissue with relative DT > 2 s but relative CBF ! 40% of contralateral. 19 We used Relative penumbra volume (%, (penumbra volume/total ischemic lesion volume) Â 100) throughout this article.
Collateral scores
If retrograde flow was seen on CTP, collaterals were graded on CTA qualitatively. 14 We defined collaterals as good (angiographic flow distal to occlusion), International Journal of Stroke, 11 (3) moderate (angiographic flow to ischemic territory but not distal to occlusion) or poor (contrast opacification only in distal superficial branches). We used a modified Miteff's classification to incorporate terminal ICA, M1 and M2 occlusion, whereas the original classification excluded M2 occlusion. 14 
Target mismatch
Target mismatch was defined as a perfusion lesion > 15 ml with core volume < 50 ml and mismatch between perfusion lesion and core > 1.8. 20 To account for the limited z-axis coverage of CTP, we reduced the 70 ml threshold used by EXTEND-IA 21 and DEFUSE-2 20 proportionately, by dividing the mean of (co-registered Infarct volume over 4 cm/total infarct volume from whole brain NCCT) in the non-recanalized group. This figure was 0.7 (i.e. approximately 70% of total infarct is in the 4 cm slab covered by CTP). This was multiplied by 70 ml to yield an adjusted volume of 50 ml to define target mismatch.
Statistical analysis
We compared the groups across three time epochs: < 180, 180-270 and > 270 min from stroke symptom onset to CTP acquisition time. We used chisquare or Fisher's tests for categorical variables and Mann-Whitney tests for continuous variables. We conducted linear regression for the prediction of penumbra proportion. We used IBM SPSS Statistics 22 version for all the statistical analysis.
Results
From a total of 263 subjects, 180 had a visible perfusion lesion on perfusion imaging, 147 of whom had anterior territory occlusion (ICA ¼ 40, M1 ¼ 60, M2 ¼ 39 M3 ¼ 8); CTP was available in 144 subjects, who constituted the main analysis population. Collateral assessment was possible in 118 with retrograde flow on CTP-SI, who constituted the population analyzed for relationship to collaterals ( Figure 1 ); 28 patients with anterograde flow distally from occlusion were excluded from collateral grading as they would not represent true collateral circulation. In the main analysis group, the overall population had median age 74 years (Interquartile Range [IQR] 63-81) and median NIHSS 15 (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . On initial imaging, median ASPECT score was 7 (5-9), median core volume 23 ml (IQR 11-48) and median penumbra volume 42 ml (IQR 25-65). Occlusion was present in the ICA (or tandem) in 39 (27%), MCA M1 segment in 59 (41%), M2 in 38 (26%) and M3 in 8 (5%). Baseline characteristics Excluded without a perfusion = in the subgroup of 118 with assessable collateral status did not differ from the overall study population. Baseline clinical and imaging characteristics across time epochs (<3, 3-4.5, >4.5 h) are detailed in Table 1 . There were no significant differences in baseline characteristics. Across time epochs, neither proportions of penumbra (59%, 64%, 75% at <3, 3-4.5, >4.5 h, respectively, p ¼ 0.4; Figure 2 ), penumbra volumes (41 (22-58), 46 (32-69), 40 (26-76) at <3, 3-4.5, >4.5 h, respectively, p ¼ 0.3; Figure 2 ), target mismatch (56%, 74%, 67% at <3, 3-4.5, >4.5 h, respectively, p ¼ 0.09; Figure 2 ), nor poor collaterals (15/56 (27%), 14/47 (30%), 4/15 (27%) at <3, 3-4.5, >4.5 h, p ¼ 0.9; Figure 2 ) differed significantly. International Journal of Stroke, 11(3)
Median penumbra proportion was 45% with poor collaterals versus 72% with good or moderate collaterals (p < 0.001); relative penumbr volume was not clearly related to time to imaging (R 2 ¼ 0.003, p ¼ 0.5; Figure 3 ) but a trend for divergent effects by collateral status was seen (slight increase in penumbra over time with good or moderate collaterals versus reduced with poor, R 2 ¼ 0.03 for both; p ¼ 0.08; Figure 3 ). In univariate linear regression, potentially significant variables predicting proportion of penumbra (p < 0.1) were: large artery (ICA or M1) occlusion, good or moderate collaterals, time to CTP*good or moderate v poor collaterals, diabetes and NIHSS. Age, time to CTP, systolic blood pressure and blood glucose were not significant predictors of penumbra proportion (Table 2) . In multivariate linear regression, NIHSS, good or moderate collaterals versus poor collaterals remained independently significant predictors of penumbra proportion (Table 3) . We analyzed a sub-group of ICA and M1 occlusion patients (n ¼ 100) to explore whether the lack of variability in penumbra proportion also holds true in a more homogeneous group. Relative penumbra volume was not clearly related to time to imaging (R 2 ¼ 0.009, p ¼ 0.3. Supplementary Figure I can be found online with this article at http://wso.sagepub.com), but a trend for divergent effects by collateral status was again seen (slight increase in penumbra over time with good collaterals versus reduced with moderate or poor, R 2 ¼ 0.04 for both; p ¼ 0.09. Supplementary data Figure II) . International Journal of Stroke, 11(3)
Discussion
Our findings in this cross-sectional study population are consistent with previous reports showing persistence of an imaging-defined penumbra in humans, with no evidence of penumbral decline that could explain the time-dependence of therapeutic benefit from reperfusion therapy within the first 6 h after stroke onset. 13 This was the case regardless of whether penumbra was assessed by absolute volume, volume relative to core, the proportion of patients with ''target mismatch'' or the presence of favorable collateral flow patterns. The sustained presence of penumbra on imaging in human studies contradicts the assumption that the short effective time window for clinical benefit from reperfusion can be explained by steep, time dependent, penumbral decline within the first few hours from onset as observed in animal models. 1, 9, 22 Our main observation of interest was a potential divergent effect of penumbral proportion over time according to collateral status, with lower proportions of penumbra in later times being seen only among those with poor collateral flow. This observation challenges the concept of ''collateral failure'' as a general mechanism driving the loss of penumbral tissue over time, 10 and instead suggests that the collateral status at initial presentation may define a group with a different natural history and much shorter time to intervene. These observations are consistent with previous studies. Bang and colleagues 23 studied the interaction of collaterals and perfusion-diffusion mismatch (perfusion lesion defined as T max ! 4 s) and found that neither collateral grading nor mismatch lesion volumes correlated with time. Poor collaterals were independently correlated with larger infarct growth. Jung and colleagues, 15 in 44 subjects with M1 or M2 occlusion undergoing endovascular therapy within 6 hours and resulting in at least partial reperfusion, showed that elapsed time accounted for only a minor proportion of penumbra tissue (defined as T max ! 6 s) loss in good collateral grades but a larger proportion in poor collateral grades.
A wide variety of methods for collateral assessment have been proposed, 24 and only limited study of the consistency of these competing approaches has been undertaken. The approach used here, modified from that of Miteff, 14 requires time-resolved vessel imaging and may be closer to the multiphasic CTA approach developed by Goyal and colleagues 25 and deployed in the majority of patients recruited to the ESCAPE trial. Whether single-phase CTA would yield equivalent findings in clinical use is unclear, and in addition, all of these collateral assessment methods are confined to occlusions of the terminal ICA or proximal MCA. Validation using other methods of collateral assessment and in other vascular territories will be important.
Our conclusions are limited by the limited number of subjects, particularly after 4.5 h from symptom onset, and the limited range of onset-to-imaging times that were covered in our dataset. To our knowledge, this is the first CT perfusion study assessing the association of penumbra volume with time, and our patient cohort is larger than MRI-based studies reported previously. 15 Since CTP has important practical advantages over MRI, it has become more widely used in patient selection protocols, especially for recent endovascular trials, and characterization of the relationships between perfusion characteristics and collaterals for this modality are, therefore, important. We used validated thresholds 18, 26 for core and penumbra, but thresholds for CT perfusion are not uniform, and their derivation is based on limited numbers. 27 In common with the majority of imaging studies, we have to infer the persistence of a presumed time-dependent imaging appearance from cross-sectional data rather than sequential imaging in each patient. Repeated imaging studies in the acute stroke population are logistically extremely difficult because patient care may be compromised, and in addition, radiation and contrast exposure limit the repeatability of CTP. Our CT scanner had restricted brain parenchyma coverage of 4 cm on a single acquisition, requiring us to modify the definitions of ''target mismatch'' based on whole brain volumes in large detector CTP 21 or MRI studies for this more restricted brain coverage, but the 50 ml core volume criterion, while obtained by the ratio of 4 cm coverage volume to whole brain volume, has not been validated independently. It is possible that larger volume acquisition, either by undertaking two examinations for contiguous 4 cm slabs or with larger detector scanners, might disclose a different relationship from that demonstrated here, as this may improve coverage of anatomically marginal brain regions omitted by a protocol centered predominantly on the basal ganglia. It is also possible that the limited time period covered may disguise relationships between collaterals and penumbra that become evident over longer observation periods. 10 Our purpose, however, was to explore the potential relevance of these MRI-defined phenomena over the time scale relevant to early intravenous or endovascular therapy.
In conclusion, we found no decrease in the proportion of CTP-defined penumbral perfusion within perfusion lesions, or the proportion of patients with target mismatch or favorable collateral patterns within the first 6 h after stroke onset. A decline in proportion of penumbra with time was restricted to those with poor collateral status. It is, therefore, possible that collateral flow grade, rather than time since onset, might define suitability for reperfusion therapies. Given the strong effect of time on outcomes after reperfusion treatment, further investigations into the interaction between collaterals, penumbra and time is required.
